Who to call at Genentech, and when
Fundz watches for the moments Genentech starts buying, and tells you who to reach.
- An alert the day Genentech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genentech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genentech. With Fundz connected, it knows.
Contract Type
partnership
South San FranciscoManufacturingBiotechnologyHealth CareMedicalTherapeuticsresearchDescription
Baltimore Ravens tight end Mark Andrews has announced a partnership with biotech company Genentech to raise awareness of diabetic macular edema (DME). This partnership aims to encourage individuals with diabetes to prioritize their vision health and seek regular screenings.
Quick answer
Mark Andrews Partners with Genentech to Raise Awareness for Diabetic Macular Edema. (June 30, 2026). Genentech is based in South San Francisco, California, United States.
- What agreement did Genentech announce on June 30, 2026?
- Baltimore Ravens tight end Mark Andrews has announced a partnership with biotech company Genentech to raise awareness of diabetic macular edema (DME). This partnership aims to encourage individuals with diabetes to prioritize their vision health and seek regular screenings.
- What does Genentech do?
- Genentech is passionate about finding solutions for some of the world’s most difficult-to-treat conditions, using cutting-edge science to create and deliver innovative medicines worldwide.
- Where is Genentech based?
- Genentech is based in South San Francisco, California, United States.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansGenentech signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.